Skip to main content

Table 4 The values of inflammatory markers, anti-oxidative parameters and lipid peroxidation markers in CAD patients and controls

From: Correlation of trans fatty acids with the severity of coronary artery disease lesions

  Controls
n = 120
CAD patients
n = 111
Inflammatory markers (plasma)
 TNF-α pg/mL 3.22 ± 3.27 7.40 ± 3.38**
 IL-6 pg/mL 4.39 ± 1.50 7.12 ± 3.90**
 hs-CRP (mg/L) 1.22 ± 0.95 3.03 ± 2.26**
Antioxidative parameters
 FRAP μMol/L (plasma) 905.99 ± 216.76 842.00 ± 171.15*
 Thiol SH μMol/L (plasma) 308.70 ± 55.04 172.13 ± 65.55**
 Catalase (U/g HB) (RBCs) 73.83 ± 59.82 299.55 ± 11.00**
 GPX (U/g HB) (RBCs) 41.51 ± 9.70 32.55 ± 5.97**
 SOD U/g HB (RBCs) 2103.26 ± 286.12 1531.66 ± 424.55**
Lipid peroxidation markers (RBCs)
 MDA (nM/gP) (RBCs) 12.80 ± 3.42 18.01 ± 5.16**
 Conjugated diene (nM hydroperoxides / gP) (RBCs) 111.10 ± 53.46 155.99 ± 80.07**
  1. Data are presented as mean ± SD. Inflammatory markers (TNF-α, IL-6), anti-oxidative parameters (FRAP: ferric reducing ability of plasma
  2. THIOL SH Plasma protein thiols (-SH), GPX Glutathione peroxidase, SOD Superoxyde dismutases) and lipid peroxidation markers (Conjugated dienes and MDA: Malondialdehyde) levels are shown in the RBCs of controls and patients, HB hemoglobin
  3. Statistical analyses were performed with the Mann-Whitney test. Significant differences between controls and CAD patients were observed as follows; *: p < 0.05; **: p < 0.001. Two independent experiments conducted in triplicate for each CAD patients and controls were realized